Kinetic Fingerprinting Links Bacteria-Phage Interactions with Emergent Dynamics: Rapid Depletion of Klebsiella pneumoniae Indicates Phage Synergy
Abstract
:1. Introduction
2. Results
2.1. Modeling Bacteria Phage Interactions
2.2. Model Predictions
3. Discussion and Conclusions
4. Materials and Methods
4.1. Model Equations
4.2. Parameter Estimation
4.3. Experimental Methods
4.3.1. Bacteria and Phage Strains
4.3.2. Growth and Enumeration of Bacterial Cells and Infectious Phage
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Abbreviations
cfu | colony forming units |
pfu | plaque forming units |
moi | multiplicity of infection |
MDR | multi drug resistant/resistance |
Appendix A. Supporting Information
References
- Salmond, G.P.C.; Fineran, P.C. A century of the phage: Past, present and future. Nat. Rev. Microbiol. 2015, 13, 777–786. [Google Scholar] [CrossRef]
- Levin, B.R.; Bull, J.R. Population and evolutionary dynamics of phage therapy. Nat. Rev. Microbiol. 2004, 2004, 166–173. [Google Scholar] [CrossRef]
- Roach, D.R.; Debarbieux, L. Phage therapy: Awakening a sleeping giant. Emerg. Top. Life Sci. 2017, 1, 93–103. [Google Scholar] [CrossRef] [Green Version]
- Schmidt, C. Phage therapy’s latest makeover. Nat. Biotechnol. 2019, 37, 581–586. [Google Scholar] [CrossRef] [PubMed]
- Rice, L.B. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. J. Infect. Dis. 2008, 197, 1079–1081. [Google Scholar] [CrossRef]
- Tacconelli, E.; Pezzani, M.D. Public health burden of antimicrobial resistance in Europe. Lancet Infect. Dis. 2019, 2019, 4–6. [Google Scholar] [CrossRef] [Green Version]
- McCallin, S.; Sacher, J.C.; Zheng, J.; Chan, B.K. Current State of Compassionate Phage Therapy. Viruses 2019, 11, 343. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Międzybrodzki, R.; Borysowski, J.; Weber-Dąbrowska, B.; Fortuna, W.; Letkiewicz, S.; Szufnarowski, K.; Pawełczyk, Z.; Rogóż, P.; Kłak, M.; Wojtasik, E.; et al. Clinical aspects of phage therapy. Adv. Virus Res. 2012, 83, 73–121. [Google Scholar] [CrossRef] [PubMed]
- Abedon, S.T. Phage therapy dosing: The problem(s) with multiplicity of infection (MOI). Bacteriophage 2016, 6, e1220348. [Google Scholar] [CrossRef] [Green Version]
- Fauconnier, A. Phage Therapy Regulation: From Night to Dawn. Viruses 2019, 11, 352. [Google Scholar] [CrossRef] [Green Version]
- Ofir, G.; Sorek, R. Contemporary Phage Biology: From Classic Models to New Insights. Cell 2018, 172, 1260–1270. [Google Scholar] [CrossRef] [Green Version]
- Burmeister, A.R.; Abedon, S.T.; Turner, P.E. Bacteriophage Ecology. In Reference Module in Life Sciences; Elsevier: Amsterdam, The Netherlands, 2019. [Google Scholar] [CrossRef]
- Pirnay, J.P.; Blasdel, B.G.; Bretaudeau, L.; Buckling, A.; Chanishvili, N.; Clark, J.R.; Corte-Real, S.; Debarbieux, L.; Dublanchet, A.; De Vos, D.; et al. Quality and safety requirements for sustainable phage therapy products. Pharm. Res. 2015, 32, 2173–2179. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cairns, B.J.; Timms, A.R.; Jansen, V.A.A.; Connerton, I.F.; Payne, R.J.H. Quantitative models of in vitro bacteriophage-host dynamics and their application to phage therapy. PLoS Pathog. 2009, 5, e1000253. [Google Scholar] [CrossRef] [Green Version]
- Hesse, S.; Rajaure, M.; Wall, E.; Johnson, J.; Bliskovsky, V.; Gottesman, S.; Adhya, S. Phage Resistance in Multidrug-Resistant Klebsiella pneumoniae ST258 Evolves via Diverse Mutations That Culminate in Impaired Adsorption. mBio 2020, 11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hampton, H.G.; Watson, B.N.J.; Fineran, P.C. The arms race between bacteria and their phage foes. Nature 2020, 2020, 327–336. [Google Scholar]
- Roach, D.R.; Leung, C.Y.; Henry, M.; Morello, E.; Singh, D.; Di Santo, J.P.; Weitz, J.S.; Debarbieux, L. Synergy between the Host Immune System and Bacteriophage Is Essential for Successful Phage Therapy against an Acute Respiratory Pathogen. Cell Host Microbe 2017, 22, 38–47.e4. [Google Scholar] [CrossRef] [PubMed]
- Leung, C.Y.J.; Weitz, J.S. Modeling the synergistic elimination of bacteria by phage and the innate immune system. J. Theor. Biol. 2017, 429, 241–252. [Google Scholar] [CrossRef] [PubMed]
- Landsberger, M.; Gandon, S.; Meaden, S.; Rollie, C.; Chevallereau, A.; Chabas, H.; Buckling, A.; Westra, E.R.; Van Houte, S. Anti-CRISPR Phages Cooperate to Overcome CRISPR-Cas Immunity. Cell 2018, 174, 908–916.e12. [Google Scholar] [CrossRef] [Green Version]
- Zimmerman, A.E.; Howard-Varona, C.; Needham, D.M.; John, S.G.; Worden, A.Z.; Sullivan, M.B.; Waldbauer, J.R.; Coleman, M.L. Metabolic and biogeochemical consequences of viral infection in aquatic ecosystems. Nat. Rev. Microbiol. 2020, 18, 21–34. [Google Scholar] [CrossRef]
- Kesik-Szeloch, A.; Drulis-Kawa, Z.; Weber-Dabrowska, B.; Kassner, J.; Majkowska-Skrobek, G.; Augustyniak, D.; Lusiak-Szelachowska, M.; Zaczek, M.; Gorski, A.; Kropinski, A.M. Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae. Virol. J. 2013, 10, 100. [Google Scholar] [CrossRef] [Green Version]
- García, R.; Latz, S.; Romero, J.; Higuera, G.; García, K.; Bastías, R. Bacteriophage Production Models: An Overview. Front. Microbiol. 2019, 10, 1187. [Google Scholar] [CrossRef] [PubMed]
- Krysiak-Baltyn, K.; Martin, G.J.O.; Stickland, A.D.; Scales, P.J.; Gras, S.L. Computational models of populations of bacteria and lytic phage. Crit. Rev. Microbiol. 2016, 42, 942–968. [Google Scholar] [CrossRef] [PubMed]
- Sinha, S.; Grewal, R.K.; Roy, S. Modeling Bacteria-Phage Interactions and Its Implications for Phage Therapy. Adv. Appl. Microbiol. 2018, 103, 103–141. [Google Scholar] [CrossRef] [PubMed]
- Rodriguez-Gonzalez, R.A.; Leung, C.Y.; Chan, B.K.; Turner, P.E.; Weitz, J.S. Quantitative Models of Phage-Antibiotic Combination Therapy. mSystems 2020, 5, 1–13. [Google Scholar] [CrossRef] [Green Version]
- Smith, H.L.; Trevino, R.T. Bacteriophage Infection Dynamics: Multiple Host Binding Sites. Math. Model. Nat. Phenom. 2009, 4, 109–134. [Google Scholar] [CrossRef] [Green Version]
- Sousa, J.A.M.d.; Rocha, E.P.C. Environmental structure drives resistance to phages and antibiotics during phage therapy and to invading lysogens during colonisation. Sci. Rep. 2019, 9, 3149. [Google Scholar] [CrossRef]
- Herridge, W.P.; Shibu, P.; O’Shea, J.; Brook, T.C.; Hoyles, L. Bacteriophages of Klebsiella spp., their diversity and potential therapeutic uses. J. Med. Microbiol. 2020, 69, 176–194. [Google Scholar] [CrossRef]
- Bertozzi Silva, J.; Storms, Z.; Sauvageau, D. Host receptors for bacteriophage adsorption. FEMS Microbiol. Lett. 2016, 363, fnw002. [Google Scholar] [CrossRef] [Green Version]
- Squeglia, F.; Maciejewska, B.; ątka, A.; Ruggiero, A.; Briers, Y.; Drulis-Kawa, Z.; Berisio, R. Structural and Functional Studies of a Klebsiella Phage Capsule Depolymerase Tailspike: Mechanistic Insights into Capsular Degradation. Structure 2020, 28, 613–624.e4. [Google Scholar] [CrossRef]
- Schmerer, M.; Molineux, I.J.; Bull, J.J. Synergy as a rationale for phage therapy using phage cocktails. PeerJ 2014, 2, e590. [Google Scholar] [CrossRef] [Green Version]
- Erez, Z.; Steinberger-Levy, I.; Shamir, M.; Doron, S.; Stokar-Avihail, A.; Peleg, Y.; Melamed, S.; Leavitt, A.; Savidor, A.; Albeck, S.; et al. Communication between viruses guides lysis-lysogeny decisions. Nature 2017, 541, 488–493. [Google Scholar] [CrossRef] [PubMed]
- Nanda, A.M.; Thormann, K.; Frunzke, J. Impact of spontaneous prophage induction on the fitness of bacterial populations and host-microbe interactions. J. Bacteriol. 2015, 197, 410–419. [Google Scholar] [CrossRef] [Green Version]
- Guenther, S.; Huwyler, D.; Richard, S.; Loessner, M.J. Virulent bacteriophage for efficient biocontrol of Listeria monocytogenes in ready-to-eat foods. Appl. Environ. Microbiol. 2009, 75, 93–100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jault, P.; Leclerc, T.; Jennes, S.; Pirnay, J.P.; Que, Y.A.; Resch, G.; Rousseau, A.F.; Ravat, F.; Carsin, H.; Le Floch, R.; et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): A randomised, controlled, double-blind phase 1/2 trial. Lancet Infect. Dis. 2019, 19, 35–45. [Google Scholar] [CrossRef]
- Kilcher, S.; Loessner, M.J. Engineering Bacteriophages as Versatile Biologics. Trends Microbiol. 2019, 27, 355–367. [Google Scholar] [CrossRef]
- Koonin, E.V.; Wolf, Y.I. Evolution of the CRISPR-Cas adaptive immunity systems in prokaryotes: Models and observations on virus-host coevolution. Mol. Biosyst. 2015, 11, 20–27. [Google Scholar] [CrossRef] [Green Version]
- Doron, S.; Melamed, S.; Ofir, G.; Leavitt, A.; Lopatina, A.; Keren, M.; Amitai, G.; Sorek, R. Systematic discovery of antiphage defense systems in the microbial pangenome. Science 2018, 359. [Google Scholar] [CrossRef] [Green Version]
- Kim, M.; Jo, Y.; Hwang, Y.J.; Hong, H.W.; Hong, S.S.; Park, K.; Myung, H. Phage-Antibiotic Synergy via Delayed Lysis. Appl. Environ. Microbiol. 2018, 84. [Google Scholar] [CrossRef] [Green Version]
- Kortright, K.E.; Chan, B.K.; Koff, J.L.; Turner, P.E. Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria. Cell Host Microbe 2019, 25, 219–232. [Google Scholar] [CrossRef] [Green Version]
- Hsieh, P.F.; Lin, H.H.; Lin, T.L.; Chen, Y.Y.; Wang, J.T. Two T7-like Bacteriophages, K5-2 and K5-4, Each Encodes Two Capsule Depolymerases: Isolation and Functional Characterization. Sci. Rep. 2017, 7, 4624. [Google Scholar] [CrossRef]
a | h | ||||||
---|---|---|---|---|---|---|---|
optimal | 15 | −3.4 | −10 | −5.3 | |||
top 10 | |||||||
all |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Loessner, H.; Schlattmeier, I.; Anders-Maurer, M.; Bekeredjian-Ding, I.; Rohde, C.; Wittmann, J.; Pokalyuk, C.; Krut, O.; Kamp, C. Kinetic Fingerprinting Links Bacteria-Phage Interactions with Emergent Dynamics: Rapid Depletion of Klebsiella pneumoniae Indicates Phage Synergy. Antibiotics 2020, 9, 408. https://doi.org/10.3390/antibiotics9070408
Loessner H, Schlattmeier I, Anders-Maurer M, Bekeredjian-Ding I, Rohde C, Wittmann J, Pokalyuk C, Krut O, Kamp C. Kinetic Fingerprinting Links Bacteria-Phage Interactions with Emergent Dynamics: Rapid Depletion of Klebsiella pneumoniae Indicates Phage Synergy. Antibiotics. 2020; 9(7):408. https://doi.org/10.3390/antibiotics9070408
Chicago/Turabian StyleLoessner, Holger, Insea Schlattmeier, Marie Anders-Maurer, Isabelle Bekeredjian-Ding, Christine Rohde, Johannes Wittmann, Cornelia Pokalyuk, Oleg Krut, and Christel Kamp. 2020. "Kinetic Fingerprinting Links Bacteria-Phage Interactions with Emergent Dynamics: Rapid Depletion of Klebsiella pneumoniae Indicates Phage Synergy" Antibiotics 9, no. 7: 408. https://doi.org/10.3390/antibiotics9070408
APA StyleLoessner, H., Schlattmeier, I., Anders-Maurer, M., Bekeredjian-Ding, I., Rohde, C., Wittmann, J., Pokalyuk, C., Krut, O., & Kamp, C. (2020). Kinetic Fingerprinting Links Bacteria-Phage Interactions with Emergent Dynamics: Rapid Depletion of Klebsiella pneumoniae Indicates Phage Synergy. Antibiotics, 9(7), 408. https://doi.org/10.3390/antibiotics9070408